These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 38669963

  • 1. D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results.
    Palareti G, Legnani C, Tosetto A, Poli D, Testa S, Ageno W, Pengo V, Cosmi B, Prandoni P.
    Thromb Res; 2024 Jun; 238():52-59. PubMed ID: 38669963
    [Abstract] [Full Text] [Related]

  • 2. D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants.
    Legnani C, Martinelli I, Palareti G, Ciavarella A, Poli D, Ageno W, Testa S, Mastroiacovo D, Ciammaichella M, Bucherini E, Mumoli N, Cosmi B.
    PLoS One; 2019 Jun; 14(7):e0219751. PubMed ID: 31310608
    [Abstract] [Full Text] [Related]

  • 3. D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study.
    Palareti G, Legnani C, Antonucci E, Cosmi B, Poli D, Testa S, Tosetto A, Ageno W, Falanga A, Ferrini PM, Pengo V, Prandoni P, DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators.
    Intern Emerg Med; 2020 Apr; 15(3):453-462. PubMed ID: 31691119
    [Abstract] [Full Text] [Related]

  • 4. D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study.
    Palareti G, Poli D, Ageno W, Legnani C, Antonucci E, Bucherini E, Testa S, Paoletti O, Chistolini A, Serrao A, Martinelli I, Bucciarelli P, Falanga A, Tosetto A, Sarti L, Mastroiacovo D, Cosmi B, Visonà A, Santoro RC, Zanatta N, Grandone E, Bertù L, Pengo V, Caiano L, Prandoni P.
    Blood Adv; 2022 Dec 13; 6(23):6005-6015. PubMed ID: 35914222
    [Abstract] [Full Text] [Related]

  • 5. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
    Ageno W, Cosmi B, Ghirarduzzi A, Santoro R, Bucherini E, Poli D, Prisco D, Alatri A, Pengo V, Galli L, Dentali F, Palareti G.
    Am J Hematol; 2012 Jul 13; 87(7):713-5. PubMed ID: 22488507
    [Abstract] [Full Text] [Related]

  • 6. How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review.
    Palareti G.
    Expert Rev Hematol; 2015 Feb 13; 8(1):79-88. PubMed ID: 25348806
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences.
    Lanitis T, Leipold R, Hamilton M, Rublee D, Quon P, Browne C, Cohen AT.
    BMC Health Serv Res; 2017 Jan 23; 17(1):74. PubMed ID: 28114939
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.
    Kearon C, Parpia S, Spencer FA, Schulman S, Stevens SM, Shah V, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Connors JM, Ginsberg JS, Spadafora L, Julian JA.
    J Thromb Haemost; 2019 Jul 23; 17(7):1144-1152. PubMed ID: 31033194
    [Abstract] [Full Text] [Related]

  • 10. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.
    Ann Intern Med; 2010 Oct 19; 153(8):523-31. PubMed ID: 20956709
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.
    Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P, DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators.
    Blood; 2014 Jul 10; 124(2):196-203. PubMed ID: 24879813
    [Abstract] [Full Text] [Related]

  • 14. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
    Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T, Poli D, Lim W.
    Ann Intern Med; 2008 Oct 07; 149(7):481-90, W94. PubMed ID: 18838728
    [Abstract] [Full Text] [Related]

  • 15. Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence.
    Legnani C, Cini M, Cosmi B, Carraro P, Tripodi A, Erba N, Palareti G.
    Intern Emerg Med; 2013 Apr 07; 8(3):229-36. PubMed ID: 21584847
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry.
    Avnery O, Martin M, Bura-Riviere A, Barillari G, Mazzolai L, Mahé I, Marchena PJ, Verhamme P, Monreal M, Ellis MH, RIETE Investigators.
    J Intern Med; 2020 Jan 07; 287(1):32-41. PubMed ID: 31394000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.
    Imberti D, Pomero F, Mastroiacovo D.
    Blood Transfus; 2020 Jan 07; 18(1):49-57. PubMed ID: 31184579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.